MAY 4, 2021, Vancouver, British Columbia: Wellteq Digital Health Inc. (CSE:WTEQ) (OTC:WTEQF), (the “Company” or “Wellteq”), is pleased to announce the Company’s shares are now trading in the United States of America under the symbol WTEQF. Wellteq’s shares currently trade on the Pink Open Market tier, with Wellteq having submitted its application to up list on the OTCQB® Venture Market. Wellteq also confirms that its shares are DTC (Depository Trust Company) eligible in the United States. DTC eligibility is expected to simplify the process of trading and enhance liquidity for the company’s common shares. Securities eligible to be electronically cleared and settled through DTC are considered DTC eligible. DTC eligibility enables shares of Wellteq to be distributed, settled and serviced through DTC’s automated processes, thereby taking advantage of the efficiencies created in the electronic method of clearing securities and the resulting cost benefits that DTC provides through accelerated settlement processes. Companies that are DTC eligible often experience higher trading volumes in their stock given the additional accessibility and availability of shares for trading.
“Trading on the OTC markets in the United States is another milestone for Wellteq. We anticipate increased interest from U.S. investors as trading on OTC Markets Group Inc.’s ATS and DTC eligibility will make it easier to purchase our shares. This is another example of Wellteq moving forward on all fronts as it works to build out its growing digital health and wellness business.”
“Trading on the OTC markets in the United States is another milestone for Wellteq,” said Scott Montgomery, CEO of Wellteq Digital Health. “We anticipate increased interest from U.S. investors as trading on OTC Markets Group Inc.’s ATS and DTC eligibility will make it easier to purchase our shares. This is another example of Wellteq moving forward on all fronts as it works to build out its growing digital health and wellness business.”
wellteq Digital Health Inc. is a leading global provider of personalized digital health and wellness
solutions across the continuum of care.
To learn more, visit https://wellteq.co/
Download the wellteq Corporate Presentation:
https://wellteq.co/about/investors/
wellteq Investor Contact:
Glen Akselrod
Bristol Investor Relations
E: glen@bristolir.com
T: (905) 326-1888
Cautionary Note Regarding Forward-Looking Statements:
This news release contains information or statements that constitute “forward-looking statements.” Such forward looking statements
involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements, or
developments to differ materially from the anticipated results, performance or achievements expressed or implied by such forwardlooking statements. Forward-looking statements are statements that are not historical facts and are generally, but not always, identified
by words such as “expects,” “plans,” “anticipates,” “believes,” “intends,” “estimates,” “projects,” “potential” and similar expressions, or
that events or conditions “will,” “would,” “may,” “could” or “should” occur.
Forward looking information may include, without limitation, statements regarding the operations, business, financial condition, expected
financial results, performance, prospects, opportunities, priorities, targets, goals, ongoing objectives, milestones, strategies and outlook of
Wellteq, and includes statements about, among other things, future developments and the future operations, strengths and strategies of
Wellteq. Forward-looking information is provided for the purpose of presenting information about management’s current expectations
and plans relating to the future and readers are cautioned that such statements may not be appropriate for other purposes. These
statements should not be read as guarantees of future performance or results.
The forward-looking statements made in this news release are based on management’s assumptions and analysis and other factors that
may be drawn upon by management to form conclusions and make forecasts or projections, including management’s experience and
assessments of historical trends, current conditions and expected future developments. Although management believes that these
assumptions, analyses and assessments are reasonable at the time the statements contained in this news release are made, actual results
may differ materially from those projected in any forward-looking statements. Examples of risks and factors that could cause actual
results to materially differ from forward-looking statements may include: the timing and unpredictability of regulatory actions; regulatory,
legislative, legal or other developments with respect to its operations or business; limited marketing and sales capabilities; early stage of
the industry and product development; limited products; reliance on third parties; unfavourable publicity or consumer perception; general
economic conditions and financial markets; the impact of increasing competition; the loss of key management personnel; capital
requirements and liquidity; access to capital; the timing and amount of capital expenditures; the impact of COVID-19; shifts in the demand
for Wellteq’s products and the size of the market; patent law reform; patent litigation and intellectual property; conflicts of interest; and
general market and economic conditions.
The forward-looking information contained in this news release represents the expectations of Wellteq as of the date of this news release
and, accordingly, is subject to change after such date. Readers should not place undue importance on forward-looking information and
should not rely upon this information as of any other date. Wellteq undertakes no obligation to update these forward-looking statements
in the event that management’s beliefs, estimates or opinions, or other factors, should change.
The CSE has neither approved nor disapproved the contents of this news release.